Dermata Therapeutics Inc.

NASDAQ: DRMA · Real-Time Price · USD
5.90
0.09 (1.55%)
At close: Aug 15, 2025, 1:01 PM

Dermata Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.16M 7.44M 6.24M 10.8M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a 540.5M 703.19M 55.72K
Receivables
n/a 8.36K 12.6K n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a 14.5K n/a 55.72K
Total Current Assets
3.53M 7.98M 6.94M 11.62M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a 540.5M 703.19M 55.72K
Total Assets
3.53M 7.98M 6.94M 11.62M
Account Payables
808.01K 866.03K 496.7K 515.25K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
731.63K 716.49K n/a n/a
Total Current Liabilities
1.97M 1.62M 922.63K 1.52M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
1.16B n/a n/a n/a
Total Long-Term Liabilities
1.16B 757.59M n/a n/a
Total Liabilities
1.97M 1.62M 922.63K 1.52M
Total Debt
n/a n/a n/a n/a
Common Stock
252.00 393.00 1.23K 833.00
Retained Earnings
-65.68M -53.39M -45.59M -35.98M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
1.56M 6.36M 6.02M 10.11M
Total Investments
3.16B n/a n/a n/a